Structure/Function Claims vs. Disease Claims: The One FDA Distinction That Determines Whether Your Marketing Is Legal

If you understand exactly one thing about FDA enforcement of healthcare marketing, understand this: the difference between a legal structure/function claim and an illegal disease claim is the line that every warning letter is drawn on. Most clinic owners think they know where the line is. After reading a few hundred warning letters, the pattern is clear - they are usually wrong by exactly one or two words.

This article walks through what the distinction actually is in the FDA’s own regulatory framework, why it exists, how to keep structure/function claims on the legal side of the line, and the five specific traps that turn an otherwise-compliant claim into a disease claim by accident.

The core distinction in plain English

The FDA regulates drugs and devices based on their intended use. Intended use is determined by what you say the product or procedure is for - not by what it biologically does. This is the part that confuses almost every new clinic owner.

A product becomes a drug when you say it treats, cures, prevents, or mitigates a disease. It does not matter whether the statement is true. It does not matter whether you have clinical data. The claim itself changes the regulatory classification.

This creates two fundamentally different types of claim:

• Structure/function claimsdescribe what a product or procedure does to the structure or function of the human body without reference to a named disease state. Example: “supports joint comfort,” “maintains healthy immune function.” These claims are legal for unapproved products with appropriate disclaimers.
• Disease claimsdescribe what a product or procedure does to a named disease, diagnosable medical condition, or specific pathology. Example: “cures arthritis,” “treats chronic fatigue syndrome.” These claims require FDA approval for the specific indication. Without that approval, the claim is illegal.

Why this distinction exists

The line exists because the FDA drug-approval process (for small molecules and biologics) and the device-clearance process (510(k), De Novo, PMA) are built around a specific assertion: that this product, for this indicated use, at this dose and route, is safe and effective. Removing the indicated use from that assertion breaks the entire regulatory framework.

If any compound could be marketed as a cure for any condition without going through the approval process, no drug company would ever pay for an approval. The structure/function-versus-disease line is what keeps the approval system intact.

The FDA does not care whether your treatment works. It cares whether you are saying it works for something that requires approval.

The five traps that convert a compliant claim into a disease claim

Trap 1: Naming the condition in any form

This is the most common error and the most straightforward to fix. The moment you name a specific medical condition - arthritis, fibromyalgia, chronic pain, alopecia, rosacea, depression, erectile dysfunction, diabetes, endometriosis - in proximity to your product, you have made a disease claim.

Trap 2: Implying the condition without naming it

The FDA is not impressed by creative paraphrasing. Describing a disease by its symptoms, referring to it by a slang or consumer label, or using an image or context that unambiguously identifies the condition is treated as if the condition had been named.

Trap 3: Treatment language

The verbs treat, cure, heal, reverse, restore, repair, and eliminate are red-flag verbs in healthcare marketing. Each one implies a medical intervention for a medical condition.

Trap 4: Drug-like language even for non-drug products

Describing a procedure, device, or supplement using pharmaceutical idiom (“therapeutic dose,” “targeted treatment,” “indicated for”) is a disease claim even when the underlying product is not a drug.

Trap 5: Testimonials that do the disease claim for you

A testimonial that makes a disease claim is a disease claim made by the clinic. You cannot outsource the regulatory status of the claim by pointing at the patient who said it. If you publish the testimonial on a channel you control, you own the claim.

How to write structure/function claims that still sell

The biggest concern most practice owners have about structure/function language is that it sounds weaker than disease-claim language. It does not have to. The trick is to lean into specific, verifiable patient experience rather than vague abstractions.

Use specific body-system or function language

Rather than soft abstractions (“supports wellness”), name the structure or function concretely (“supports normal joint comfort,” “supports healthy cellular energy production”).

Report patient experience, do not assert clinical outcome

“Some patients report” is regulatory gold. It is a factual claim about what patients said - which is substantiable - rather than a claim about what the treatment medically does.

Keep individual-variation language in every testimonial

“Individual results vary. These results are not typical and are not guaranteed.” This disclosure is not legal boilerplate you can omit; it is part of what makes a featured patient story substantiable under FTC endorsement guidance.

Do not let marketing creative override clinical honesty

If a claim is too ambitious to phrase without using a disease word, the answer is not to phrase it more cleverly. The answer is to stop making that claim publicly. Keep aspirational results inside your clinical conversations, not inside your ad set.

Special cases that trip up specific specialties

Regenerative medicine and stem cell

The combination of “stem cell” + any disease name is the highest-density FDA warning-letter trigger in healthcare right now. Even structure/function language can tip into disease-claim territory when paired with stem-cell terminology. Err aggressively toward patient- experience language.

Med spa and aesthetics

Cosmetic conditions that also have a medical classification - rosacea, acne, alopecia, hyperpigmentation, hyperhidrosis - are disease territory. “Reduces the appearance of” is compliant language; “treats” or “cures” the same condition is not.

GLP-1 and weight-loss clinics

Weight loss itself is structure/function territory when phrased in general health terms. Obesity, diabetes, and metabolic syndrome are disease territory. Compounded GLP-1s have additional drug-identity complications that structure/function language does not solve.

IV therapy and wellness

NAD+, glutathione, high-dose vitamin C, and hormone-adjacent IV protocols are frequently marketed with disease-claim language for chronic fatigue, brain fog, migraine, and depression. All four are diagnosable medical conditions; none of those claims are legal.

Dental and cosmetic dentistry

Structural claims about implants, crowns, and veneers are generally safe if they do not extend into medical outcomes. “Lifetime” and “permanent” guarantees are separate FTC issues independent of the FDA disease-claim line.

Applying this to your own marketing this week

1. List every medical condition named anywhere in your public marketing. Site, ads, captions, emails. Every instance is a candidate for rewrite or removal.
2. Scan your service pages for treatment verbs. Any occurrence of cure, heal, reverse, restore, repair, eliminate, or treat tied to a procedure is a direct rewrite target.
3. Pull every testimonial and mark the ones naming a condition. Either re-solicit a compliant version or remove it.
4. Add “individual results vary” as a default footer on any page or post that features an outcome description.